LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

HOLLENCREST CAPITAL MANAGEMENT's Holding History (CIK: 0001161722)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 29 Value ($000) $0 Avg Close $1.40 Range $1.16 - $1.58